Age Predicts Cancer Incidence Better Than Statin-Induced Low-Density Lipoprotein Level

Journal of the American College of Cardiology

Volumn 51, Issue 1, 2008, Pages 90-91

  Rembold, Christopher M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; PRAVASTATIN; SIMVASTATIN;

AGING; CANCER INCIDENCE; CANCER RISK; CORONARY ARTERY ATHEROSCLEROSIS; HEART INFARCTION; HUMAN; ISCHEMIA; LETTER; LOGISTIC REGRESSION ANALYSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

AGE FACTORS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; LIPOPROTEINS, LDL; NEOPLASMS; RISK FACTORS;

EID: 37449014310     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.08.054     Document Type: Letter

References (1)

1. Alsheikh-Ali A.A., Maddukuri P.V., Han H., and Karas R.H. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer. J Am Coll Cardiol 50 (2007) 409-418